The Washington Post: The Trump administration is taking on drug prices – but not drug companies

The Washington Post: The Trump administration is taking on drug prices – but not drug companies

The PCMA cited federal government data to argue that providing rebates to patients at the pharmacy counter would drive up consumers’ premiums by $28 billion